- Antibiotic price drop could stop millions from developing tuberculosis: New agreement secures 66% reduction in cost of rifapentine, which prevents ‘latent’ TB from becoming active. Available to those who could afford it, it has, until now, been “completely unaffordable” in developing countries. https://www.theguardian.com/global-development/2019/oct/31/antibiotic-price-drop-could-stop-millions-from-developing-tuberculosis 3 comments worldnews
Linked pages
- 600 years’ supply of cystic fibrosis drug destroyed in price row | Cystic fibrosis | The Guardian https://www.theguardian.com/society/2019/mar/27/600-years-supply-of-cystic-fibrosis-drug-destroyed-in-price-row 47 comments
- MSF Access Campaign | Médecins Sans Frontières http://www.msfaccess.org/ 40 comments
Related searches:
Search whole site: site:www.theguardian.com
Search title: Antibiotic price drop could stop millions from developing tuberculosis | Global health | The Guardian
See how to search.